U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H14O
Molecular Weight 150.2176
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of O-CYMEN-5-OL

SMILES

CC(C)C1=CC=C(O)C=C1C

InChI

InChIKey=IJALWSVNUBBQRA-UHFFFAOYSA-N
InChI=1S/C10H14O/c1-7(2)10-5-4-9(11)6-8(10)3/h4-7,11H,1-3H3

HIDE SMILES / InChI

Molecular Formula C10H14O
Molecular Weight 150.2176
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

O-Cymen-5-OL is an antifungal preservative used in cosmetics and beauty products to prevent harmful bacteria from developing and to prolong the shelf-life of formulas. It is part of the Isopropyl Cresols family and is originally developed synthetically in the form of a crystal. O-Cymen-5-OL is also used as a cosmetic biocide, or ingredient that helps to cleanse the skin or to prevent odor by destroying or inhibiting the growth of microorganisms, according to research. O-Cymen-5-OL is approved by the FDA for use as a direct and indirect food additive and has been approved by the CIR for use in cosmetics up to .5% concentration. However, in the European Union, it is only approved for use up to .1%. Studies in Japan, some dating back to 1956, found O-Cymen-5-OL to be neurotoxic in animals and have led to heavier restrictions on its use in cosmetics there. O-Cymen-5-OL (Dekasol BL) is used in oral care, to fight periodontal disease.

Approval Year

PubMed

PubMed

TitleDatePubMed
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.
2006-11
Final report on the safety assessment of sodium p-chloro-m-cresol, p-chloro-m-cresol, chlorothymol, mixed cresols, m-cresol, o-cresol, p-cresol, isopropyl cresols, thymol, o-cymen-5-ol, and carvacrol.
2006
Patents

Sample Use Guides

O-Cymen-5-OL has been approved by the CIR for use in cosmetics up to .5% concentration.
Route of Administration: Topical
In Vitro Use Guide
Curator's Comment: o-Cymen-5-ol minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined against Streptococcus mutans, Actinomyces viscosus, Porphyromonas gingivalis, Fusobacterium nucleatum and Candida albicans.
o-Cymen-5-ol MIC was between 1.7 mM to 3.4 mM; MBC was 3.4 mM to 6.7 mM.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:08:17 GMT 2025
Edited
by admin
on Mon Mar 31 18:08:17 GMT 2025
Record UNII
H41B6Q1I9L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
O-CYMEN-5-OL
INCI  
INCI  
Official Name English
NSC-62111
Preferred Name English
PHENOL, 3-METHYL-4-(1-METHYLETHYL)-
Systematic Name English
ISOPROPYLMETHYLPHENOL
Systematic Name English
4-I-PROPYL-3-METHYLPHENOL
Common Name English
2-CYMEN-5-OL
Systematic Name English
4-ISOPROPYL-3-METHYLPHENOL
Systematic Name English
3-METHYL-4-(PROPAN-2-YL)PHENOL
Systematic Name English
P-THYMOL
Common Name English
4-ISOPROPYL-M-CRESOL
Systematic Name English
DEKACYMEN
Common Name English
3-METHYL-4-(1-METHYLETHYL)PHENOL
Systematic Name English
3-METHYL-4-(PROPAN-2-YL)BENZOLOL
Common Name English
4-ISOPROPYL-3-METHYL-PHENOL
Systematic Name English
O-Cymen-5y-ol [WHO-DD]
Common Name English
CYMEN-5-OL, O-
Common Name English
Code System Code Type Description
ECHA (EC/EINECS)
221-761-7
Created by admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
PRIMARY
EPA CompTox
DTXSID10186026
Created by admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
PRIMARY
DAILYMED
H41B6Q1I9L
Created by admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
PRIMARY
SMS_ID
100000132789
Created by admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
PRIMARY
EVMPD
SUB48260
Created by admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
PRIMARY
MESH
C512394
Created by admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
PRIMARY
FDA UNII
H41B6Q1I9L
Created by admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
PRIMARY
NSC
62111
Created by admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
PRIMARY
CAS
3228-02-2
Created by admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
PRIMARY
PUBCHEM
18597
Created by admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
PRIMARY
RXCUI
1364387
Created by admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
PRIMARY RxNorm